BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31237113)

  • 1. High immune cytolytic activity in tumor-free tongue tissue confers better prognosis in patients with squamous cell carcinoma of the oral tongue.
    Gu X; Boldrup L; Coates PJ; Fahraeus R; Wang L; Wilms T; Norberg-Spaak L; Sgaramella N; Nylander K
    J Pathol Clin Res; 2019 Oct; 5(4):240-247. PubMed ID: 31237113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic and Immunophenotypic Characterization of Tumor Immune Microenvironment in Squamous Cell Carcinoma of the Oral Tongue.
    Chatzopoulos K; Sotiriou S; Collins AR; Kartsidis P; Schmitt AC; Chen X; Khazaie K; Hinni ML; Ramsower CA; Zarka MA; Patel SH; Garcia JJ
    Head Neck Pathol; 2021 Jun; 15(2):509-522. PubMed ID: 33010009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma.
    Hori Y; Kubota A; Yokose T; Furukawa M; Matsushita T; Katsumata N; Oridate N
    Laryngoscope; 2021 Nov; 131(11):2512-2518. PubMed ID: 33955550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the immune profile of oral tongue squamous cell carcinomas with advancing disease.
    Meehan K; Leslie C; Lucas M; Jacques A; Mirzai B; Lim J; Bulsara M; Khan Y; Wong NC; Solomon B; Sader C; Friedland P; Mir Arnau G; Semple T; Lim AM
    Cancer Med; 2020 Jul; 9(13):4791-4807. PubMed ID: 32383556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis.
    Troiano G; Rubini C; Togni L; Caponio VCA; Zhurakivska K; Santarelli A; Cirillo N; Lo Muzio L; Mascitti M
    Cancer Med; 2020 Nov; 9(22):8333-8344. PubMed ID: 33047888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-Infiltrating CD1a
    Ni YH; Zhang XX; Lu ZY; Huang XF; Wang ZY; Yang Y; Dong YC; Jing Y; Song Y; Hou YY; Hua ZC; Hu QG
    Pathol Oncol Res; 2020 Jul; 26(3):1687-1695. PubMed ID: 31606786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic evaluation of host immune microenvironment and its prognostic significance in oral tongue squamous cell carcinoma: a comparative study on lymphocytic host response (LHR) and tumor infiltrating lymphocytes (TILs).
    Xu B; Salama AM; Valero C; Yuan A; Khimraj A; Saliba M; Zanoni DK; Ganly I; Ghossein R; Patel SG; Katabi N
    Pathol Res Pract; 2021 Dec; 228():153473. PubMed ID: 34059347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combined histo-score based on tumor differentiation and lymphocytic infiltrate is a robust prognostic marker for mobile tongue cancer.
    Bjerkli IH; Hadler-Olsen E; Nginamau ES; Laurvik H; Søland TM; Costea DE; Uhlin-Hansen L; Steigen SE
    Virchows Arch; 2020 Dec; 477(6):865-872. PubMed ID: 32607687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation Challenges in the Validation of B7-H3 as Oral Tongue Cancer Prognosticator.
    Sieviläinen M; Wirsing AM; Hyytiäinen A; Almahmoudi R; Rodrigues P; Bjerkli IH; Åström P; Toppila-Salmi S; Paavonen T; Coletta RD; Hadler-Olsen E; Salo T; Al-Samadi A
    Head Neck Pathol; 2021 Jun; 15(2):469-478. PubMed ID: 32959211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of TAP1 in Tumor-Free Tongue Contralateral to Squamous Cell Carcinoma of the Oral Tongue, an Indicator of Better Survival.
    Attaran N; Gu X; Coates PJ; Fåhraeus R; Boldrup L; Wilms T; Wang L; Sgaramella N; Zborayova K; Nylander K
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD163
    Shigeoka M; Koma YI; Nishio M; Komori T; Yokozaki H
    Clin Exp Dent Res; 2019 Dec; 5(6):627-637. PubMed ID: 31890299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
    Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
    Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Tumor-infiltrating Lymphocytes Predicts the Behavior of Early-stage Oral Tongue Cancer.
    Heikkinen I; Bello IO; Wahab A; Hagström J; Haglund C; Coletta RD; Nieminen P; Mäkitie AA; Salo T; Leivo I; Almangush A
    Am J Surg Pathol; 2019 Oct; 43(10):1392-1396. PubMed ID: 31290758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma.
    Xie N; Wang C; Liu X; Li R; Hou J; Chen X; Huang H
    J Oral Pathol Med; 2015 Apr; 44(4):266-72. PubMed ID: 25169851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNM staging compared with a new clinicopathological model in predicting oral tongue squamous cell carcinoma survival.
    Okuyemi OT; Piccirillo JF; Spitznagel E
    Head Neck; 2014 Oct; 36(10):1481-9. PubMed ID: 23996811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy.
    Chen YP; Wang YQ; Lv JW; Li YQ; Chua MLK; Le QT; Lee N; Colevas AD; Seiwert T; Hayes DN; Riaz N; Vermorken JB; O'Sullivan B; He QM; Yang XJ; Tang LL; Mao YP; Sun Y; Liu N; Ma J
    Ann Oncol; 2019 Jan; 30(1):68-75. PubMed ID: 30407504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal categorization in early oral tongue cancer.
    Almangush A; Bello IO; Heikkinen I; Hagström J; Haglund C; Kowalski LP; Nieminen P; Coletta RD; Mäkitie AA; Salo T; Leivo I
    Virchows Arch; 2021 May; 478(5):925-932. PubMed ID: 32955604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peritumoral cuffing by T-cell tumor-infiltrating lymphocytes distinguishes HPV-related oropharyngeal squamous cell carcinoma from oral cavity squamous cell carcinoma.
    Poropatich K; Hernandez D; Fontanarosa J; Brown K; Woloschak G; Paintal A; Raparia K; Samant S
    J Oral Pathol Med; 2017 Nov; 46(10):972-978. PubMed ID: 28632936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune cell infiltration in head and neck squamous cell carcinoma and patient outcome: a retrospective study.
    Schneider K; Marbaix E; Bouzin C; Hamoir M; Mahy P; Bol V; Grégoire V
    Acta Oncol; 2018 Sep; 57(9):1165-1172. PubMed ID: 29493423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T-cell infiltration in tongue squamous cell carcinoma.
    Hanakawa H; Orita Y; Sato Y; Takeuchi M; Ohno K; Gion Y; Tsukahara K; Tamamura R; Ito T; Nagatsuka H; Nishizaki K; Yoshino T
    Acta Otolaryngol; 2014 Aug; 134(8):859-64. PubMed ID: 24921153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.